Long COVID-19: a new risk factor for autoimmune diseases and lymphoma?

Authors

Downloads

Download data is not yet available.

References

Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020;324(8):782-93. DOI: https://doi.org/10.1001/jama.2020.12839

Deer RR, Rock MA, Vasilevsky N, Carmody L, Rando H, Anzalone AJ, et al. Characterizing Long COVID: Deep Phenotype of a Complex Condition. EBioMedicine. 2021;74. DOI: https://doi.org/10.1016/j.ebiom.2021.103722

Gold JE, Okyay RA, Licht WE, Hurley DJ. Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation. Pathogens. 2021;10(6):763. DOI: https://doi.org/10.3390/pathogens10060763

Gaspar-Rodríguez A, Padilla-González A, Rivera-Toledo E. Coronavirus persistence in human respiratory tract and cell culture: An overview. The Brazilian Journal of Infectious Diseases. 2021;25(5):101632. DOI: https://doi.org/10.1016/j.bjid.2021.101632

Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23(2):1-7. DOI: https://doi.org/10.1038/s41590-021-01113-x

Schiffner J, Backhaus I, Rimmele J, Schulz S, Möhlenkamp T, Klemens JM, et al. Long-Term Course of Humoral and Cellular Immune Responses in Outpatients After SARS-CoV-2 Infection. Front Public Health. 2021;9:732-87. DOI: https://doi.org/10.3389/fpubh.2021.732787

Ortona E, Malorni W. Long COVID: to investigate immunological mechanisms and sex/gender related aspects as fundamental steps for a tailored therapy. European Respiratory Journal. 2021;59(2):2102245. DOI: https://doi.org/10.1183/13993003.02245-2021

Chen J, Dai L, Barrett L, Post SR, Qin Z. SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus. Commun Biol. 2021;4(1):682. DOI: https://doi.org/10.1038/s42003-021-02220-z

Shannon-Lowe C, Rickinson AB, Bell AI. Epstein–Barr virus-associated lymphomas. Philos Trans R Soc Lond B Biol Sci. 2017;372(1732):20160271. DOI: https://doi.org/10.1098/rstb.2016.0271

Published

2023-08-13

How to Cite

1.
Pichardo Rodriguez R, Saavedra Velazco M, Bracamonte Hernández J-J, Córdova-Cueva L, de la Cruz-Vargas JA. Long COVID-19: a new risk factor for autoimmune diseases and lymphoma?. Rev Cuba Med Tropical [Internet]. 2023 Aug. 13 [cited 2025 Apr. 2];75(1). Available from: https://revmedtropical.sld.cu/index.php/medtropical/article/view/1012

Issue

Section

Cartas al editor